Furthermore, in all MASLD patients complement 2 was repressed (Figure S12A,B), and except of C2, COLEC10 and C4BPB, the correlation between FGF21 and the expression of complement factors was strictly negative. Here, C4BPB is linked to metabolic dysfunction-associated steatotic liver disease.